Q3 of FY2019-20 records Rs.23.18 lacs PAT at Trident Texofab

Trident Texofab announced its standalone financial results for the quarter and period ended on December 31, 2019.

Standalone financial results for the quarter and period ended 31st December, 2019 at Trident Texofab shows depreciation in profit margin despite increase in revenue as compared to a year ago period.

Below are the Q3 standalone financials of FY2019-20 at Trident Texofab:

• PAT stood at Rs.23.18 lacs whereas previous year same period it was Rs.24.80 lacs
• Revenue reached Rs.19.99 crore as compared to Rs.16.82 crore in a year ago period.
• EPS was Rs.0.58 whereas previous year corresponding period it was Rs.0.62

Following are the financials at Trident Texofab for the first nine months period in FY19-20:

• PAT stood at Rs.50.81 lacs against Rs.88.45 lacs in a previous year corresponding period.
• EPS is Rs.1.27 whereas last year corresponding period it was Rs.2.21
• Revenue earned was Rs.68.80 crore whereas last year same period it was Rs.55.41 crore.

By the end of standalone financial result for FY2018-19 at Trident Texofab, revenue was Rs.87.22 crore, PAT was Rs.1.27 crore and EPS was Rs.3.19.

\n\n

\n Result\n

\nRs. in Lacs\n

\n \n \n\n\n\n\n\n\n\n\n \n\n\n\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n\n\n\n\n \n \n\n\n\n\n\n\n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n

	Quarter Ended	Quarter Ended	Current Year Upto	Previous Year Upto	Previous Year
	31/12/2019	31/12/2018	31/12/2019	31/12/2018	2018-2019
Income Statement
Revenue	1992.15	1674.07	6857.94	5518.74	8689.74
Other Income	7.19	8.52	22.22	22.55	32.27
Total Income	1999.34	1682.59	6880.16	5541.29	8722.01
Expenditure	1851.17	1615.57	6465.34	5316.42	8436.18
Interest	102.33	29.33	276.90	113.63	86.47
PBDT	45.83	37.69	137.92	111.24	199.36
Depreciation	20.73	12.89	59.50	22.79	30.39
PBT	25.10	24.8	78.42	88.45	168.97
Tax	1.92	0.00	27.61	0.00	41.55
Net Profit	23.18	24.8	50.81	88.45	127.42
Equity	399.59	399.59	399.59	399.59	399.59
EPS	0.58	0.62	1.27	2.21	3.19